Subsequently, we investigated the potential for converting the DCM pathology observed in Δ3–7 hiPSC-CMs closer to that of Δ3–9 hiPSC-CMs through the partial restoration of Δ3–9 dystrophin via AO administration. The gene discussed is DMD; the disease is familial dilated cardiomyopathy.